Developing technologies that modulate the human microbiome – the collective genome of the microbes in and on the body – OptiBiotix Health a life sciences company identifies and develops microbial strains, compounds and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health benefits.
With an established pipeline of microbiome modulators, the OptiBiotix team works today in the prevention and management of chronic lifestyle diseases including obesity, hypercholesterolemia and lipid profiles, and diabetes.
OptiBiotix is at the leading edge of this evolving market and, with its validated technology platforms, is well positioned to exploit increasing public, political and investor interest in this field.
Lactobacillus plantarum LPLDL® is OptiBiotix’s next generation probiotic. Scientifically proven to lower cholesterol by 36.7%, LDL cholesterol by 13.9%, blood pressure by 5.1% and increase HDL cholesterol by 4.5%. Full FDA GRAS and can be manufactured to GMP.
SlimBiome® is OptiBiotix’s multi award-winning weight management ingredient. Transforming the way weight loss is traditionally approached, SlimBiome® offers a healthy, hunger-free weight management system that is backed by strong scientific principles. A highly functional ingredient, SlimBiome® promotes the feeling of fullness, helps burn calories by promoting a healthy metabolism and maintains blood sugar levels to reduce food cravings.